Cytokinetics may be worth $90+ a share in potential deal ami

Cytokinetics may be worth $90+ a share in potential deal amid Phase 3 data - UFP

Cytokinetics may be worth $90+ a share in potential deal amid Phase 3 data - UFP

seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

San Francisco , California , United States , Switzerland , , Bloomberg , United First , United First Partners , First Partners , Healthcare Conference ,